Clinical Nephrology, Volume 106 (2026) - August (137 - 149)

Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model

Xinyu Wang1*, Lu Song2*, Qin Lv1*, Li Li3, Qiao Wang3, Chunli Liu3, Meiyu Chen3, Feifei Liu1, Yaling Yu1, Ying Shen1, Jianchen Cui4, Yaxi Zhao5, Qinyuan Deng1
1 Department of Nephrology, 2 Department of Integrated Traditional Chinese and Western Medicine, 3 Department of Nephrology, The First People’s Hospital of Yunnan Province, School of Medicine, Kunming University of Science and Technology, 4 Department of Sleep Medicine, The First People’s Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, and 5 Department of Clinical Nutrition, The Second People’s Hospital of Kunming, Kunming, China

     

 

DOI 10.5414/CN112016

Abstract

Aim: Chronic kidney disease and biological aging share overlapping mechanisms, but conventional risk models may not adequately capture their combined impact on mortality. This study aimed to determine whether integrating DNA methylation–based biological age (epigenetic age) with renal function estimates could enhance mortality risk prediction.
Materials and methods: A mortality risk model incorporating estimated glomerular filtration rate was developed in the UK Biobank and externally validated in the National Health and Nutrition Examination Survey (1999 – 2002). Four epigenetic age measures (Horvath, Hannum, PhenoAge, and GrimAge) were evaluated for their added value in predicting mortality. Model performance was assessed using discrimination metrics and survival analyses.
Results: Among the epigenetic age measures, GrimAge showed the most substantial improvement in model performance when combined with creatinine-based kidney function estimates. Adding GrimAge improved discrimination for mortality prediction (change in C-statistic: 0.16; p < 0.001). In the external cohort, individuals classified as low risk by chronological age but as high risk by GrimAge had significantly higher mortality. Chronological age-adjusted kidney function showed no predictive value, while GrimAge-based models identified at-risk individuals with preserved kidney function. Models using creatinine outperformed those using cystatin C across all measures of biological age.
Conclusion: Integrating epigenetic age measures with renal function indicators improves mortality prediction. GrimAge is particularly effective in identifying individuals at high risk who may not be detected using standard approaches. Incorporating biological aging markers into kidney health assessments may allow more precise and personalized risk stratification.

*These authors contributed equally to this work and share first authorship.

Author Details

Authors

Departments

  • 1 Department of Nephrology,
  • 2 Department of Integrated Traditional Chinese and Western Medicine,
  • 3 Department of Nephrology, The First People’s Hospital of Yunnan Province, School of Medicine, Kunming University of Science and Technology,
  • 4 Department of Sleep Medicine, The First People’s Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, and
  • 5 Department of Clinical Nutrition, The Second People’s Hospital of Kunming, Kunming, China

Address

Dr. Qinyuan Deng
157 Jinbi Road, Xishan District,
Kunming, Yunnan, 650032, China
or
Yaxi Zhao, MD, No.1579 Beijing Road
Panlong District, Kunming, Yunnan, 650000, China
Email: [email protected]; [email protected]

Citation

Xinyu Wang, Lu Song, Qin Lv, Li Li, Qiao Wang, Chunli Liu, Meiyu Chen, Feifei Liu, Yaling Yu, Ying Shen, Jianchen Cui, Yaxi Zhao, Qinyuan Deng.Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model
. Clin Nephrol. 2026; 106: 137-149. doi: 10.5414/CN112016. Pubmed: https://pubmed.ncbi.nlm.nih.gov/42165591/; PMID: 42165591.

###article_not_exists_msg###

Warenkorb Übersicht

Warenkorb Übersicht
Typ Anz Rabatt MwSt Preis
Der Warenkorb ist leer
Ihr Warenkorb